Compounding pharmacies operating under Section 503B play a critical role in the pharmaceutical supply chain, producing sterile medications at scale while meeting stringent regulatory standards. Achieving and maintaining compliance with current Good Manufacturing Practice (cGMP) requires more than technical expertise—it demands highly controlled environments and increasingly sophisticated operational processes. Read More >